Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis

Rheumatology (United Kingdom)

Volumn 54, Issue 4, 2014, Pages 707-711

  Vigone, Barbara ^a   Santaniello, Alessandro ^a   Marchini, Maurizio ^a   Montanelli, Gaia ^a   Caronni, Monica ^a   Severino, Adriana ^a   Beretta, Lorenzo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Classification criteria; Human leucocyte antigens; Systemic sclerosis

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ5DR1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIGEN FUNCTION; ARTICLE; DISEASE COURSE; GENETIC RISK; HAPLOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PRIORITY JOURNAL; RISK REDUCTION; SURVIVAL TIME; SYSTEMIC SCLEROSIS;

EID: 84926434517     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu381     Document Type: Article

References (20)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67.
2. Koenig M, Joyal F, Fritzler MJ et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-12.
3. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
4. Valentini G, Vettori S, Cuomo G et al. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther 2012;14:R188.
5. Valentini G, Marcoccia A, Cuomo G et al. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody or capillaroscopic positivity or both. Arthritis Care Res 2014 Feb 10. [Epub ahead of print].
6. van den Hoogen F, Khanna D, Fransen J et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747-55.
7. Beretta L, Rueda B, Marchini M et al. Analysis of class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology 2012;51:52-9.
8. Arnett FC, Gourh P, Shete S et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010;69:822-7.
9. Cutolo M, Sulli A, Pizzorni C et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-60.
10. Solomon DH, Kavanaugh AJ, Schur PH. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434-44.
11. Dalva K, Beksac M. Sequence-specific primed PCR (PCRSSP) typing of HLA class I and class II alleles. Methods Mol Med 2007;134:51-60.
12. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
13. Cheverud JM. A simple correction for multiple comparisons in interval mapping genome scans. Heredity 2001;87:52-8.
14. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993;118:201-10.
15. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34.
16. Cutolo M, Pizzorni C, Tuccio M et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004;43:719-26.
17. Toledo Del Rio AP, Sachetto Z, Degrava Sampaio-Barros P et al. HLA markers for poor prognosis in systemic sclerosis Brazilian patients. Dis Markers 2013;35:73-78.
18. Sato H, Woodhead FA, Ahmad T et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 2010;19:4100-11.
19. Chari S, Dworkin I. The conditional nature of genetic interactions: the consequences of wild-type backgrounds on mutational interactions in a genome-wide modifier screen. PLoS Genet 2013;9:e1003661.
20. Ralph P, Coop G. The geography of recent genetic ancestry across Europe. PLoS Biol 2013;11:e1001555.